NEW YORK (360Dx) – Bio-Rad Laboratories said after the close of the market on Monday that the US Food and Drug Administration has cleared the company's IH-500 automated random access system for blood typing and screening.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.